The Model for End-stage Liver Disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice

Journal of Clinical Gastroenterology

Volumn 41, Issue 4, 2007, Pages 412-415

  Antaki, Fadi ^a,c   Lukowski, Anna ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Hospice; Liver cirrhosis; MELD; Prognosis; Survival

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HOSPICE; HOSPITAL DISCHARGE; HUMAN; LIVER CIRRHOSIS; MALE; MEDICAL RECORD REVIEW; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOCIAL SECURITY; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL TIME; TIME OF DEATH;

AGED; FEMALE; HOSPICES; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RETROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TERMINAL CARE;

EID: 34147118685     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225594.01201.9b     Document Type: Article

References (11)

1. Stuart B, Alexander C, Arenella C. Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. 2nd ed. Arlington, VA: National Hospice Organization; 1996.
2. Fox E, Landrum-McNiff K, Zhong Z, et al. Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. JAMA. 1999;282:1638-1645.
3. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;320:469-473.
4. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864-871.
5. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
6. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease and allocation of donor livers. Gastroenterology. 2003;124:91-96.
7. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transplant. 2004;10:7-15.
8. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia: Sanders; 1964:50-58.
9. Hospice Facts and Figures. Arlington, VA: National Hospice and Palliative Care Organization; 2003.
10. Wallston KA, Burger C, Smith RA, et al. Comparing the quality of death for hospice and non-hospice cancer patients. Med Care. 1988;26:177-182.
11. Christakis NA, Escarce JJ. Survival of medicare patients after enrollment in hospice programs. N Engl J Med. 1996;335:172-178.